Company / Profit Margin
TScan Therapeutics, Inc. Profit Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-4527.7%
FY2025
5-year range
-4527.7% / -423.9%
FY2021-FY2025
Trend
-968.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -968% YoY in FY2025, a notable deviation from the 4-year average annual change of -219%.
Based on SEC 10-K filings.
-4527.7% in FY2025 with a 3-year CAGR of -4048.2%.
Declined from -489.3% to -4527.7% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -4048.2pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 968.2% year-over-year.
- Peak profit margin was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -9.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -4527.7% | -968.2% |
| FY2024 | -423.9% | +13.4% |
| FY2023 | -489.3% | -2.0% |
| FY2022 | -479.5% | +80.1% |
| FY2021 | -2408.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026